Safe use of glucocorticoids. How to monitor patients taking these potent agents
Cook, D.M.
Postgraduate Medicine 91(3): 145-9 152-4
1992
ISSN/ISBN: 0032-5481 PMID: 1741359 Document Number: 396227
Glucocorticoids reduce inflammation and combat stress. However, they are very powerful, and guidelines for their use must be followed to avoid such adverse effects as Cushing's syndrome and adrenal insufficiency. Whenever possible, physicians should consider alternative treatment strategies, because the consequences of steroid therapy may be worse than those of the disease being treated.
Document emailed within 1 workday
Related Documents
Kajita, S.; Iizuka, H.; Hirokawa, M.; Tsutsui, M.; Mizumoto, T. 1986: Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo Acta Dermato-Venereologica 66(6): 491-496Otsea, K.; Benson, J.; Alemayehu, T.; Pearson, E.; Healy, J. 2011: Testing the Safe Abortion Care model in Ethiopia to monitor service availability, use, and quality International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 115(3): 316-321
Niemegeers, C.J.; Schellekens, K.H.; Van Bever, W.F.; Janssen, P.A. 1976: Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs Arzneimittel-Forschung 26(8): 1551-1556
Otsea, K.; Benson, J.; Alemayehu, T.; Pearson, E.; Healy, J. 2011: Testing the Safe Abortion Care Model in Ethiopia to Monitor Service Availability, Use, and Quality : Averting Maternal Death and Disability International Journal of Gynaecology and Obstetrics 115(3): 316-321
Kumar, P.; Agarwal, J.C.; Nath, C.; Bhargava, K.P.; Shanker, K. 1981: Substituted dopamine quinazolones as potent antiparkinsonian agents Die Pharmazie 36(11): 780
2003: Older tricyclic antidepressants were potent suicide-agents Lakartidningen 100(18): 1651-1652
Egerton, J.R.; Ostlind, D.A.; Blair, L.S.; Eary, C.H.; Suhayda, D.; Cifelli, S.; Riek, R.F.; Campbell, W.C. 1979: Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component Antimicrobial Agents and Chemotherapy 15(3): 372-378
Maikhuri, J.P.; Dwivedi, A.K.; Dhar, J.D.; Setty, B.S.; Gupta, G. 2003: Mechanism of action of some acrylophenones, quinolines and dithiocarbamate as potent, non-detergent spermicidal agents Contraception 67(5): 403-408
Ghosh, S.; Narla, R.K.; Zheng, Y.; Liu, X.P.; Jun, X.; Mao, C.; Sudbeck, E.A.; Uckun, F.M. 1999: Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents Anti-Cancer Drug Design 14(5): 403-410
Malhotra, M.; Sharma, R.; Sanduja, M.; Kumar, R.; Jain, J.; Deep, A. 2012: Synthesis, characterization and evaluation of mannich bases as potent antifungal and hydrogen peroxide scavenging agents Acta Poloniae Pharmaceutica 69(2): 355-361
Malhotra, M.; Hans, P.; Sharma, S.; Deep, A.; Phogat, P. 2012: Synthesis and characterization of (Z)-N-(1-[2-{3-[(dimethylamino)methyl)]-2-methoxyphenyl}-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl]ethylidene) benzenamine derivatives as potent antifungal agents Acta Poloniae Pharmaceutica 69(3): 433-438
Ashwin, J. 1983: Agencies cooperate in ensuring safe use of antineoplastic agents Canadian Medical Association Journal 128(8): 907-908
Massa, S.; Stefancich, G.; Corelli, F.; Silvestri, R.; Panico, S.; Artico, M.; Simonetti, N. 1988: Researches on antibacterial and antifungal agents. IX--Pyrrole analogues of bifonazole with potent antifungal activities Il Farmaco; Edizione Scientifica 43(9): 693-704
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
McLean, W.; Boucher, E.A.; Brennan, M.; Holbrook, A.; Orser, R.; Peachey, J.; Sellers, E. 2000: Is there an indication for the use of barbiturate-containing analgesic agents in the treatment of pain? Guidelines for their safe use and withdrawal management. Canadian Pharmacists Association Canadian Journal of Clinical Pharmacology 7(4): 191-197
Liu, G.Z.; Li, P. 2001: A PC-based pulse oximetry monitor for four patients Zhongguo Yi Liao Qi Xie Za Zhi 25(3): 136-138; 185
Dormidontov, E.N.; Korshunov, N.I.; Baranova, E.I.; Zheltkevich, S.N.; Razumova, E.B. 1985: Use of high doses of glucocorticoids in patients with rheumatic diseases Terapevticheskii Arkhiv 57(8): 12-16
Millat, B.; Borie, F. 1998: Is it necessary to monitor patients surgically treated for colorectal cancer? Journal de Chirurgie 135(4): 177-181
Pankov, A.K.; Chirvina, E.D.; Tiutiunova, A.M. 1977: Prognostic value of the level of glucocorticoids and androgens in lung cancer patients Voprosy Onkologii 23(4): 21-24
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197